Previous close | 85.05 |
Open | 85.44 |
Bid | 87.68 x 100 |
Ask | 87.99 x 100 |
Day's range | 85.29 - 88.73 |
52-week range | 49.24 - 94.57 |
Volume | |
Avg. volume | 169,017 |
Market cap | 1.579B |
Beta (5Y monthly) | 0.92 |
PE ratio (TTM) | 16.43 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | 02 July 2010 |
1y target est | N/A |
AstraZeneca (AZN) targets $80 billion in total revenues by 2030. It expects to launch 20 new medicines.
Dyne (DYN) gains 28% after reporting positive new data from two separate ongoing mid to late-stage studies evaluating DYNE-101 and DYNE-251 for different muscle disease indications.
PTC Therapeutics (PTCT) gains 21% on May 20 after the EC decided against adopting the negative CHMP opinion of January 2024 on the annual renewal of the conditional approval of Translarna.